Michigan Institute for Neurological Disorders

What Michigan Institute for Neurological Disorders does

Michigan Institute for Neurological Disorders (MIND) is a private, for-profit outpatient neurology practice founded in 1969 and headquartered in Farmington Hills, Michigan, serving patients across Southeast Michigan with a planned extension into Western Wayne County via a new Westland facility opening August 2026. The practice delivers specialized neurological care for conditions including multiple sclerosis, Parkinson's disease, Alzheimer's disease, and migraine disorders, organized around four core service lines: outpatient neurological consultations, infusion therapy, electroencephalography (EEG) testing, and electromyography (EMG) testing. Technology is limited to standard neurological diagnostic and treatment equipment — infusion pumps, EEG, and EMG systems — with no disclosed proprietary platform, software product, or AI tooling.

The business model is professional-services fee-for-service reimbursed through patient insurance, Medicare, Medicaid, and self-pay under standard healthcare provider schedules. The go-to-market motion is enterprise field sales in form only — in practice it is physician referral and patient self-referral into outpatient facilities, with no disclosed marketing channels, partnerships, or branded patient-acquisition programs. Revenue concentration risk is structurally diffuse across a broad patient population rather than concentrated in enterprise contracts; payer dependency, however, creates exposure to Medicare/Medicaid rate-setting and commercial insurer negotiations.

The company's headcount range of 51–100 employees and the announcement of a 6,777-square-foot second outpatient site suggest a regional specialty practice in steady-state expansion. Ownership and capital structure are undisclosed, as are financial metrics including revenue, profitability, funding history, and any external investment. Strategic positioning rests on clinical specialization, multi-decade regional reputation, and physical access points rather than technological defensibility or capital-backed growth.

Name

Michigan Institute for Neurological Disorders

Legal name

Michigan Institute for Neurological Disorders

Website

https://mindonline.com

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

51–100 employees

Short description

Michigan Institute for Neurological Disorders is a private outpatient neurology practice in Farmington Hills, Michigan, founded in 1969, serving Southeast Michigan patients with infusion therapy, EEG, and EMG services for neurological conditions.

Ownership category

akta.pro rank

Product category

Outpatient Neurological Care

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

akta.pro secondary industry

Neuromuscular Medicine (ALS, Myasthenia, Neuropathy) (HLAKAIAD)

Keywords

• Neurological care services
• Outpatient neurology clinic
• Diagnostic neurological testing
• Infusion therapy services
• Electrodiagnostic testing

Headquarters

HQ city

Farmington Hills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. Outpatient Neurological Services: Revenue generated from providing outpatient neurological diagnostic and treatment services including infusion therapy, EEG testing, and EMG testing. Services are reimbursed through patient insurance, Medicare, and other healthcare payer relationships.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Michigan Institute for Neurological Disorders (MIND) provides specialized outpatient neurological care, including diagnostic testing (EEG and EMG), infusion therapy, and pain management services for patients with neurological conditions such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and migraine disorders. The institute operates outpatient neurological centers in Southeast Michigan, with a new 6,777-square-foot facility scheduled to open in Westland, Michigan in August 2026.

Product overview

Michigan Institute for Neurological Disorders (MIND) is a healthcare services provider offering specialized outpatient neurological care. The institute provides a range of diagnostic and therapeutic services including infusion therapy, EEG testing, and EMG testing for conditions such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and migraine disorders. Services are delivered through outpatient neurological centers, with a new facility opening in Westland, Michigan in August 2026 to expand access in Western Wayne County.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Neurological Services Comprehensive outpatient neurological care including diagnostic testing and therapeutic treatments for patients with neurological conditions such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and migraine disorders.
• Infusion Therapy Therapeutic IV infusion treatments administered to patients with neurological conditions including multiple sclerosis and other disorders requiring intravenous medication.
• EEG Testing Electroencephalography diagnostic testing that measures and records brain activity to aid in the diagnosis of neurological conditions.
• EMG Testing Electromyography diagnostic testing that evaluates muscle and nerve function to aid in the diagnosis of neurological disorders.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Regional players

• Novant Health Neurology: Mid-Atlantic health system operating outpatient neurology programs including infusion and EEG/EMG services. Comparable business model (specialty outpatient neurology within a regional footprint) though it does not overlap MIND's Michigan geography.

Broad incumbents

• Corewell Health Neurology: Michigan-based integrated health system (formerly Beaumont Health) with a comprehensive neurology service line including outpatient EEG/EMG, infusion, and subspecialty clinics that overlap directly with MIND's offering in the same regional market.
• Ascension Michigan Neuroscience: Michigan division of Ascension Health operating outpatient neurology programs including infusion and diagnostic services. Competes for the same regional referral base in Southeast Michigan.
• Henry Ford Health Neurology: Detroit-headquartered integrated health system operating the Henry Ford Neuroscience Institute, which provides outpatient neurology, infusion, and neurodiagnostic services across Southeast Michigan — MIND's primary service area.
• Mayo Clinic Neurology: Large academic neurology department providing comprehensive outpatient neurology, infusion, and neurodiagnostic services. Comparable as a high-end specialty neurology competitor, though at national referral scale.
• Michigan Medicine Department of Neurology: University of Michigan academic neurology department providing specialty outpatient clinics, infusion, and neurodiagnostic services across Michigan. Comparable as a regional neurology competitor with broader academic and inpatient capabilities.
• Cleveland Clinic Neurological Institute: National specialty neurology institute offering integrated diagnostic, infusion, and outpatient subspecialty services. Relevant as a benchmark for specialty neurology scale, though it operates nationally rather than within MIND's regional footprint.

Direct peers

• Dent Neurologic Institute: Private, multi-site specialty neurology practice offering diagnostic testing, infusion therapy, and disease management across Western New York. Closest comparable as a large independent outpatient neurology group with an integrated infusion and neurodiagnostic service line.
• Mischer Neuroscience Institute: Specialty neuroscience center within Memorial Hermann in Houston providing integrated neurodiagnostic, infusion, and outpatient neurology services. Comparable as a focused neurology specialty platform combining diagnostics and treatment.

Emerging players

• Capital Institute for Neurosciences: Specialty neuroscience center in New Jersey offering integrated outpatient neurology, neurodiagnostics, and infusion services. Comparable in scope to MIND as a focused community-level specialty neurology platform outside Michigan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/MIND.physicians

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Michigan Institute for Neurological Disorders